TY - JOUR T1 - Assessing suppression strategies against epidemic outbreaks like COVID-19: the SPQEIR model JF - medRxiv DO - 10.1101/2020.04.22.20075804 SP - 2020.04.22.20075804 AU - Daniele Proverbio AU - Françoise Kemp AU - Stefano Magni AU - Andreas Husch AU - Atte Aalto AU - Laurent Mombaerts AU - Alexander Skupin AU - Jorge Gonçalves AU - Jose Ameijeiras-Alonso AU - Christophe Ley Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/27/2020.04.22.20075804.abstract N2 - The current COVID-19 outbreak represents a most serious challenge for societies worldwide. It is endangering the health of millions of people, and resulting in severe socioeconomic challenges due to lock-down measures. Governments worldwide aim to devise exit strategies to revive the economy while keeping the pandemic under control. The problem is that the effects of distinct measures are not well quantified. This paper compares several suppression approaches and potential exit strategies using a new extended epidemic SEIR model. It concludes that while rapid and strong lock-down is an effective pandemic suppression measure, a combination of other strategies such as social distancing, active protection and removal can achieve similar suppression synergistically. This quantitative understanding will support the establishment of mid- and long-term interventions. Finally, the paper provides an online tool that allows researchers and decision makers to interactively simulate diverse scenarios with our model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDP and SM's work is supported by the FNR PRIDE DTU CriTiCS, ref 10907093. FK's work is supported by the Luxembourg National Research Fund PRIDE17/12244779/PARK-QC. A.H. work was partially supported by the Fondation Cancer Luxembourg. JG is partly supported by the 111 Project on Computational Intelligence and Intelligent Control, ref B18024. AA is supported by the Luxembourg National Research Fund (FNR) (Project code: 13684479). JAA is supported by the FWO research project G.0826.15N (Flemish Science Foundation), GOA/12/014 project (Research Fund KU Leuven), Project MTM2016-76969-P from the Spanish State Research Agency (AEI) co-funded by the European Regional Development Fund (ERDF) and the Competitive Reference Groups 2017-2020 (ED431C 2017/38) from the Xunta de Galicia through the ERDF.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data are used. Simulation code is publicly available. https://github.com/daniele-proverbio/Covid-19 ER -